FDA Recall of Olympus Endoscope Reprocessor OER-Pro

FDA Recalls medium FDA · · United States

The FDA has announced a recall of 3,354 units of the Olympus Endoscope Reprocessor OER-Pro due to incompatibility issues with certain reprocessing components.

What this fda recalls alert tells you, and what most readers miss

This notice was issued by FDA on April 8, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.

Most readers skim an alert like this, check whether they are personally affected, and move on. The more useful lens is to read the alert as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar alerts have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized fda recalls advisory is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.

For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, Devices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.

What Happened

The Olympus Endoscope Reprocessor OER-Pro is being recalled because the MAJ-1443 and MAJ-1444 components are no longer compatible with it and the OER-Elite automated endoscope reprocessors.

Which Products Are Affected

The affected product is the Olympus Endoscope Reprocessor OER-Pro with Model Number: N3058140. It includes UDI-DI: 04953170258589 and Catalog Number: N3058140. All Lot/Serial Numbers are included, with a total of 3,354 units distributed nationwide in the United States.

What You Should Do

Consumers should follow the instructions in the initial firm notification letter from Olympus Corporation of the Americas for further guidance on this voluntary recall.

Why This Matters

This recall involves medical devices used in healthcare settings, which could affect patient safety due to potential incompatibility issues.

Source

Attribution: FDA. For more information, visit the FDA website and search for Recall Number Z-1613-2026.

Source: FDA Official Notice

Related Articles

Frequently Asked Questions

What is this fda recalls alert about?
The FDA has announced a recall of 3,354 units of the Olympus Endoscope Reprocessor OER-Pro due to incompatibility issues with certain reprocessing components.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more fda recalls alerts?
Browse all fda recalls alerts on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.